Bococizumab is a remarkable anti-PCSK9 antibody effectively developed to address hypercholesterolemia. This therapeutic agent works by the PCSK9 protein, a key regulator of cholesterol levels. By blocking the activity https://bookmarklinking.com/story10795705/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia